Coronary Artery Disease, Family History, and Screening Perspectives: An Up-to-Date Review
- PMID: 39407893
- PMCID: PMC11477357
- DOI: 10.3390/jcm13195833
Coronary Artery Disease, Family History, and Screening Perspectives: An Up-to-Date Review
Abstract
Family history for CAD (coronary artery disease) is an established cardiovascular (CV) risk factor and it is progressively acquiring importance in patients' CV risk stratification. Numerous studies have demonstrated that individuals with a first-degree relative affected by CAD have a significantly higher risk of developing the condition themselves; in particular, when CAD occurs at an early age in relatives. Indeed, recently published CCS (chronic coronary syndrome) ESC (European Society of Cardiology) guidelines include family history (FH) as a risk factor to consider when calculating pre-test risk for CAD. ESC guidelines on preventive cardiology (2021) only suggested CV risk assessment in the presence of a positive FH for CV disease, not considering it in the actual risk scores. Evidence suggests that positive anamnesis for relatives affected by CAD correlates with ACS (acute coronary syndrome) and CAD, with slight differences in relative risk as far as the degree of kinship is concerned. Genetic factors contribute to this correlation by influencing key processes that affect heart health, such as cholesterol metabolism, blood pressure regulation, and inflammatory responses. New technologies in the genetics field are increasing the availability of genome sequencing, and new polymorphism panels are being tested as predictive for CAD, objectifying familiarity. Advances in imaging techniques allow the assessment of coronary atherosclerosis and its composition, and these are acquiring strength in evidence and recommendations in ESC guidelines as a way to define coronary disease in low and low-to-intermediate risk patients and to guide medical therapy and interventional procedures. Use of these emerging tools to guide screening is likely to be extended, beyond high CV risk patients, to individuals with FH for early CAD and/or specific genetic profiles, as recent evidence in the literature is suggesting.
Keywords: cardiac CT; coronary artery disease; family history for CAD; high-risk plaques.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
API expert consensus document on management of ischemic heart disease.J Assoc Physicians India. 2006 Jun;54:469-80. J Assoc Physicians India. 2006. PMID: 16909697 Review.
-
Cardiac CT findings in patients with family history of premature CAD: an observational study.Acta Cardiol. 2022 Sep;77(7):580-585. doi: 10.1080/00015385.2021.1967612. Epub 2021 Aug 25. Acta Cardiol. 2022. PMID: 34431450
-
64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(11):1-44. Epub 2010 Jun 1. Ont Health Technol Assess Ser. 2010. PMID: 23074388 Free PMC article.
-
2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.Acta Cardiol Sin. 2023 Jan;39(1):4-96. doi: 10.6515/ACS.202301_39(1).20221103A. Acta Cardiol Sin. 2023. PMID: 36685161 Free PMC article.
-
Critical appraisal of inflammatory markers in cardiovascular risk stratification.Crit Rev Clin Lab Sci. 2014 Oct;51(5):263-79. doi: 10.3109/10408363.2014.913549. Epub 2014 Jun 11. Crit Rev Clin Lab Sci. 2014. PMID: 24918900 Review.
Cited by
-
A-kinase anchoring protein 1: an independent predictor of coronary artery disease.BMC Cardiovasc Disord. 2025 Mar 7;25(1):156. doi: 10.1186/s12872-025-04613-y. BMC Cardiovasc Disord. 2025. PMID: 40055597 Free PMC article.
-
Complete Versus Incomplete Revascularization in Elderly Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis.Cureus. 2024 Nov 20;16(11):e74068. doi: 10.7759/cureus.74068. eCollection 2024 Nov. Cureus. 2024. PMID: 39712780 Free PMC article. Review.
-
Characterization and risk stratification of coronary artery disease in people living with HIV: a global systematic review.Front Cardiovasc Med. 2025 Aug 12;12:1586019. doi: 10.3389/fcvm.2025.1586019. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40873612 Free PMC article.
-
Nanomedicine in cardiovascular and cerebrovascular diseases: targeted nanozyme therapies and their clinical potential and current challenges.J Nanobiotechnology. 2025 Jul 28;23(1):543. doi: 10.1186/s12951-025-03590-w. J Nanobiotechnology. 2025. PMID: 40717066 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous